Medium-Chain Fatty Acids Improve Cognitive Function in Intensively Treated Type 1 Diabetic Patients and Support In Vitro Synaptic Transmission During Acute Hypoglycemia - Page, Kathleen A.; Williamson, Anne; Yu, Namyi; McNay, Ewan C.; Dzuira, James; McCrimmon, Rory J.; Sherwin, Robert S. (Diabetes (New York, N.Y.), 2009)
Keywords: 3-Hydroxybutyric Acid - therapeutic use; Acute Disease; Biological and medical sciences; Brain research; Care and treatment; Catheters; Cognition & reasoning; Cognition - drug effects; Cognition - physiology; Cognition disorders; Cognition Disorders - drug therapy; Cognition Disorders - etiology; Cognition Disorders - psychology; Cognitive ability; Cognitive disorders; Complications and side effects; Diabetes; Diabetes Mellitus, Type 1 - blood; Diabetes Mellitus, Type 1 - drug therapy; Diabetes Mellitus, Type 1 - psychology; Diabetes. Impaired glucose tolerance; Endocrine pancreas. Apud cells (diseases); Endocrinopathies; Etiopathogenesis. Screening. Investigations. Target tissue resistance; Fatty acids; Fatty Acids, Nonesterified - pharmacology; Fatty Acids, Nonesterified - therapeutic use; Glucose; Glucose Clamp Technique; Health aspects; Humans; Hypoglycemia; Hypoglycemia - drug therapy; Hypoglycemia - psychology; Insulin; Medical sciences; Memory - drug effects; Memory - physiology; Original; Patient outcomes; Prevention; Research design; Risk factors; Synaptic Transmission - drug effects; Synaptic Transmission - physiology; Triglycerides; Triglycerides - therapeutic use; Type 1 diabetes; United States; Endocrinopathy; Human; Immunopathology; Support; Type 1 diabetes; Synaptic transmission; Lipids; Autoimmune disease; Metabolic diseases; Hypoglycemia; Fatty acids; In vitro